Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for Chronic Stable Angina in Overweight Non-Diabetic Patients
NCT00225355Phase 4Terminated
- Sponsor
- University of Glasgow
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in angina pectoris, sponsored by University of Glasgow. Started Feb 2006; status: terminated.
02
Drugs
rosiglitazone
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT00225355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225355.